Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Obi Pharma Inc.
Sponsor

Obi Pharma Inc.

6 F. No. 508 Sec. 7, Zhongxiao E. Rd, Nangang Dist., 115011

About the sponsor

Obi Pharma Inc. is focused on breast cancer research, with activity centered on triple negative breast cancer and related treatment development.

  • Triple negative breast cancer
  • Breast cancer
  • Oncology

The sponsor’s clinical work in this area reflects interest in disease-specific therapeutic strategies for aggressive malignancies with limited targeted treatment options.

About Specializations

Obi Pharma Inc. runs clinical trials in conditions such as Triple negative breast cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Triple negative breast cancer

Not recruiting
Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Obi Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.